Medical News Today: Drug that prevents chemotherapy-induced nausea and vomiting wins FDA approval

Regulators have approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and vomiting, a side effect that can disrupt patients' lives and their therapy.